RecruitingPhase 2Phase 3NCT06752616

Acute Agitation in Emergency Psychiatry

Advancing the Quality of Treatment and Care for Acute Agitation in Emergency Psychiatry

Sponsor

Lone Baandrup

Enrollment

132 participants

Start Date

Dec 30, 2024

Study Type

INTERVENTIONAL

Conditions

Agitation

Summary

The purpose of the study is to improve the pharmacological treatment of psychiatric patients with acute agitation.

Eligibility

Min Age: 18 YearsMax Age: 64 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Buccal midazolam, a drug called Oral lorazepam, and others for people with agitation. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 64 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.